TG Therapeutics | TGTX - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
AbbVie USD 3.63B 54M 2026-06
Alaunos Therapeutics USD 447K 138K 2026-03
Amgen USD 1.72B 134M 2026-06
Ardelyx USD 102.27M 26.35M 2026-03
Arrowhead Research USD 46.63M 4.88M 2026-06
Bayer EUR 3.96B 267M 2026-06
Biogen USD 709.7M 155.4M 2026-06
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Curis USD 2.96M 1.62M 2026-03
Gilead Sciences USD 1.52B 70M 2026-06
J&J USD 6.42B 381M 2026-06
Karyopharm Therapeutics USD 10.42M 861K 2026-03
Novartis USD 3.24B 101M 2026-06
Novavax USD 25.53M 1.34M 2025-12
PTC Therapeutics USD 73.89M 13.31M 2026-03
Puma Biotechnology USD 16.82M 8.15M 2024-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06
Verastem USD 22.3M 2.14M 2026-03
Vertex Pharmaceuticals USD 582.2M 88.5M 2026-06